Anuj Agarwal, MD
Internal Medicine · Tampa, FLNPI 1598298614
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,247 of the $2,078 with a category attached, or 60.0%. Olympus Corporation Of The Americas accounts for 65.5% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2024 at $1,472 and has fallen 90.4% since, to $142 in 2025.
Across 25 payments — averaging $83.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus Corporation Of The Americas$1K
- E.r. Squibb & Sons, L.L.C.$246
- Sanofi$114
- Saluda Medical Americas, Inc.$81
- Cardiva Medical, Inc.$78
- United Therapeutics Corporation$49
- plus $149 from 7 others
What the payments were for
- Travel & lodging$1,24760%
- Food & beverage$83140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus Corporation Of The Americas | 10 | $1,361 |
| E.r. Squibb & Sons, L.L.C. | 2 | $246 |
| Sanofi | 1 | $114 |
| Saluda Medical Americas, Inc. | 1 | $81 |
| Cardiva Medical, Inc. | 2 | $78 |
| United Therapeutics Corporation | 2 | $49 |
| Merck | 1 | $32 |
| Pharmacosmos Therapeutics Inc. | 1 | $26 |
| Verona Pharma, Inc. | 1 | $24 |
| AstraZeneca | 1 | $21 |
| AbbVie | 1 | $17 |
| Viatris Specialty LLC | 1 | $15 |
| Aurinia Pharma U.S., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,078 in reported general payments places this provider in the 80th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 11 | $269 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Tampa
- Andrew KuykendallTampa$322K
- Jhanelle GrayTampa$229K
- Anitha ReddyTampa$224K
- Benjamin CreelanTampa$212K
- Anne HermannTampa$139K
- Mark LaflammeTampa$119K
- Shahla BariTampa$56K
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.